[1]World Health Organization. Global tuberculsis report 2013. Geneva: World Health Organization,2013.[2]Keshavjee S,Girard F,Harrington M,et al. Time for a bold new vision at the Stop TB Partnership. Lancet,2010,376(9749):1283-1284.[3]Francis ML,Fan XS,Meltzer MS. Loss ability to produce IFN-alpha in response to HIV-1 as monocytes differentiate into macrophages. Induction through a mechanism independent of double-stranded RNA.J Immunol,1996, 156(7):2481-2487.[4]Bogdan C.The function of type Ⅰ interferons in antimicrobial immunity. Curr Opin Immunol, 2000, 12(4):419-424.[5]Vigario AM, Belnoue E, Cumano A,et al. Inhibition of Plasmodium yoelii blood-stage malaria by interferon alpha through the inhibition of the production of its target cell, the reticulocyte. Blood, 2001, 97(12):3966-3971.[6]Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev,2001,14(4):778-809.[7]García JC, Ariza AM, Lasa AM, et al. Increased antiviral activity of microscale-purified HuIFN alpha 8 (human interferon alpha 8) over HuIFN alpha 2b in Hep-2 cells challenged with Mengo virus. Biotechnol Appl Biochem,2007,48 (Pt 3):159-165.[8]Kohanbash G, Ishikawa E, Fujita M, et al. Differential activity of interferon-α8 promoter is regulated by Oct-1 and a SNP that dictates prognosis of glioma. Oncoimmunology,2012, 1(4):487-492.[9]Kempaiah P, Anyona SB, Raballah E, et al. Reduced inter-feron (IFN)-α conditioned by IFNA2 (-173) and IFNA8 (-884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and longitudinal all-cause mortality. Hum Genet, 2012, 131(8):1375-1391.[10]Teles RM, Graeber TG,Krutzik SR,et al. Type Ⅰ interferon suppresses type Ⅱinterferon-triggered human anti-mycobacterial responses.Science,2013, 339(6126):1448-1453.[11]Novikov A, Cardone M, Thompson R, et al. Mycobacterium tuberculosis triggers host type Ⅰ IFN signaling to regulate IL-1β production in human macrophages. J Immunol,2011,187(5):2540-2547.[12]中华医学会. 临床诊疗指南:结核病分册.北京:人民卫生出版社,2005:1-47.[13]中华医学会结核病学分会. 肺结核诊断和治疗指南.中华结核和呼吸杂志,2001,24(2):70-74.[14]Chen X, Yang Q, Zhang M, et al. Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol,2009,16(6):879-884.[15]Zhang G, Zhou B, Wang W, et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis, 2012, 205(11): 1697-1704.[16]Zhang G, Chen X, Chan L, et al. An SNP selection strategy identified IL-22 associating with susceptibility to tuberculosis in Chinese. Sci Rep, 2011,1:20.[17]Young DB, Perkins MD, Duncan K,et al. Confronting the scien-tific obstacles to global control of tuberculosis. J Clin Invest, 2008,118(4): 1255-1265.[18]Thye T,Vannberg FO, Wong SH,et al.Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet, 2010,42(9): 739-741.[19]Ward CM, Jyonouchi H, Kotenko SV, et al. Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency.Eur J Pediatr,2007, 166(9):981-985.[20]Pandey AK, Yang Y, Jiang Z,et al. NOD2, RIP2 and IRF5 play a critical role in the type Ⅰ interferon response to Mycobacterium tuberculosis. PLoS Pathog,2009, 5(7):e1000500. |